Potassium%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an essential electrolyte used to treat or prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. ## Adult Dosing * **Oral:** * Prevention: 20 mEq (1.5 g) once daily to 40 mEq (3 g) divided twice daily. * Treatment: 40 mEq (3 g) to 100 mEq (7.5 g) per day, divided into 2-5 doses. Maximum daily oral dose is generally considered 200 mEq. * **Intravenous (IV):** * Treatment of severe hypokalemia or when oral therapy is not feasible. Dosing depends on serum potassium levels, ECG findings, and patient's clinical status. * IV KCL administration must be diluted in an IV fluid and infused slowly. **Never administer IV KCL undiluted or as a bolus.** * Concentration: Typically no more than 40 mEq/L in peripheral lines; higher concentrations (e.g., up to 80 mEq/L or more) may be used in central lines with cardiac monitoring, but this requires strict adherence to local protocols and continuous ECG monitoring. * Infusion Rate: Generally no faster than 10-20 mEq/hour. Faster rates (up to 40 mEq/hour or higher) may be used in life-threatening situations with continuous ECG monitoring and central venous access, but this carries a significant risk of hyperkalemia and cardiac arrest. ## Pediatric Dosing * **Oral:** * Prevention: 1-2 mEq/kg/day divided into 1-2 doses. Maximum daily dose typically 3 mEq/kg/day or 200 mEq/day, whichever is less. * Treatment: 2-5 mEq/kg/day divided into 2-4 doses. Maximum daily dose typically 3 mEq/kg/day or 200 mEq/day, whichever is less. * **Intravenous (IV):** * Dosing is highly individualized based on serum potassium and clinical status. * Concentration: Similar to adults, typically limited to 40 mEq/L in peripheral lines. Higher concentrations require central access and continuous monitoring. * Infusion Rate: Generally no faster than 0.5-1 mEq/kg/hour (maximum of 20 mEq/hour). Faster rates may be used in emergent situations with continuous ECG monitoring. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Potassium excretion is significantly reduced in patients with renal insufficiency, increasing the risk of hyperkalemia. Doses should be significantly reduced, and frequent monitoring is essential. ## Contraindications * Hyperkalemia. * Conditions where potassium levels may rise, such as severe renal impairment, untreated Addison's disease, anuria, severe burns, or crushing injuries. * Use of potassium-sparing diuretics or ACE inhibitors without careful monitoring in patients prone to hyperkalemia. * Known hypersensitivity to potassium chloride. ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal discomfort. * **Serious:** Hyperkalemia (which can cause muscle weakness, paralysis, arrhythmias, cardiac arrest), gastrointestinal ulceration, bleeding, or perforation (especially with sustained-release oral formulations). ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors and Angiotensin Receptor Blockers (ARBs):** Increased risk of hyperkalemia. * **NSAIDs:** May reduce the antihypertensive effect of potassium supplements and increase the risk of hyperkalemia. * **Salt substitutes:** Often contain potassium chloride, which can lead to increased potassium intake and hyperkalemia. ## Monitoring * **Serum potassium levels:** Essential, especially during IV administration, with dose changes, or in patients with renal impairment or risk factors for hyperkalemia. * **Renal function (BUN, creatinine):** To assess potential for potassium retention. * **ECG:** To detect signs of hyperkalemia (e.g., peaked T waves, prolonged QRS) particularly during rapid IV infusions or in high-risk patients. * **Signs and symptoms of hyperkalemia:** Nausea, vomiting, muscle weakness, paresthesias, arrhythmias. ## Clinical Pearls * Oral potassium chloride should be taken with meals or a full glass of water to minimize gastrointestinal upset and the risk of esophageal irritation or ulceration. * Sustained-release formulations are often less irritating to the stomach but may have variable absorption. * IV potassium is a vesicant and can cause pain and phlebitis at the infusion site. * Hypokalemia can be exacerbated by diuretics, vomiting, diarrhea, and poor dietary intake. * The underlying cause of hypokalemia should be identified and treated. This information is for educational purposes and does not substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines for complete details.